Essilorluxottica ESLOF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ESLOF is a good fit for your portfolio.
News
-
EssilorLuxottica Shares Climb After Eyewear Giant Draws Big Tech Interest
-
Ray-Ban Maker EssilorLuxottica Backs Midterm Targets After Profit Rises
-
Trending: Meta Eyeing Stake in Ray-Ban Parent EssilorLuxottica
-
Meta in talks to buy a near $5 billion stake in Ray-Ban sunglasses parent: WSJ
-
Vans parent VF Corp. sells Supreme skating brand to France's EssilorLuxottica for $1.5 billion in cash
-
Ray-Ban Maker EssilorLuxottica to Buy Supreme Brand From VF for $1.5 Billion — 2nd Update
-
EssilorLuxottica to Buy Supreme Brand From VF for $1.5 Billion — Update
-
EssilorLuxottica to Buy Supreme Brand From VF for $1.5 Billion
Trading Information
- Previous Close Price
- $217.84
- Day Range
- $217.55–228.06
- 52-Week Range
- $163.17–232.87
- Bid/Ask
- $217.55 / $232.57
- Market Cap
- $99.11 Bil
- Volume/Avg
- 694 / 585
Key Statistics
- Price/Earnings (Normalized)
- 28.84
- Price/Sales
- 3.55
- Dividend Yield (Trailing)
- 1.97%
- Dividend Yield (Forward)
- 1.97%
- Total Yield
- 2.19%
Company Profile
EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses. Both companies are significantly larger than the next biggest player in their respective fields and command over 15% of the fragmented global eyewear market. The company has a broad geographical presence, with around 36% of sales in Europe, 47% in North America, and the rest in Asia and Latin America.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Growth
- Total Number of Employees
- 193,693
- Website
- https://www.essilorluxottica.com
Competitors
Valuation
|
Metric
|
ESLOF
|
COO
|
|---|---|---|
Price/Earnings (Normalized) | 28.84 | 27.37 |
Price/Book Value | 2.37 | 2.38 |
Price/Sales | 3.55 | 4.99 |
Price/Cash Flow | 16.87 | 20.27 |
Price/Earnings
ESLOF
COO
Financial Strength
|
Metric
|
ESLOF
|
COO
|
|---|---|---|
Quick Ratio | 0.54 | 0.84 |
Current Ratio | 0.88 | 1.95 |
Interest Coverage | 15.06 | 5.25 |
Quick Ratio
ESLOF
COO
Profitability
|
Metric
|
ESLOF
|
COO
|
|---|---|---|
Return on Assets (Normalized) | 4.24% | 2.88% |
Return on Equity (Normalized) | 6.72% | 4.48% |
Return on Invested Capital (Normalized) | 5.28% | 4.10% |
Return on Assets
ESLOF
COO
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Xjddvbvh | Yhthq | $156.8 Bil | |||
| Becton Dickinson & Co
BDX
| Rgnvwsvm | Hkgsys | $68.6 Bil | |||
| Alcon Inc
ALC
| Vvxlcmpx | Pdbjjny | $46.5 Bil | |||
| Coloplast A/S ADR
CLPBY
| Tqgqjfwv | Lxwd | $29.1 Bil | |||
| ResMed Inc
RMD
| Xzbvkynxwb | Bzhbyzx | $28.9 Bil | |||
| West Pharmaceutical Services Inc
WST
| Spgxxbms | Mvdz | $20.7 Bil | |||
| The Cooper Companies Inc
COO
| Bszsykt | Msdck | $18.6 Bil | |||
| Hologic Inc
HOLX
| Zgzgxgmft | Xrbgtjn | $18.4 Bil | |||
| Baxter International Inc
BAX
| Gvfrrcwd | Jjffgl | $18.1 Bil | |||
| Teleflex Inc
TFX
| Dnnp | Pjnw | $10.4 Bil |